Prognostic Factors for Visual Outcomes Following the First Episode of NMOSD-Related Optic Neuritis in Affected Eyes [Corrigendum]

Thongmee W, Padungkiatsagul T, Jindahra P, Khongkhatithum C, Thampratankul L, Vanikieti K. Clin Ophthalmol. 2020;14:4271–4278. Table 5 on page 4276, the 95% CI and the p-value for the Time from initial ocular symptoms (pain and/or visual loss) to IVMP in each affected eye (days) row are incorrect. Table 5 on page 4276, the 95% CI and the p-value for the BCVA at nadir better than CF row are incorrect. The correct Table 5 is shown below. Table 5 Univariate Analysis The authors apologize for these errors and advise they do not affect the conclusions of the study

Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study

To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC)